Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: improvement with high-dose intravenous immunoglobulin therapy.

M. Lopez-Sublet H. Bihan G. Reach Sophie Dupont 1 A. Didelot J.-J. Mourad A. Krivitzky R. Dhote
1 NEMESIS-CRICM - Equipe NEMESIS - Centre de Recherches de l'Institut du Cerveau et de la Moelle épinière
CRICM - Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière
Abstract : Glutamic acid decarboxylase antibodies (GAD-abs) are an immunological factor involved in type 1 diabetes and other diseases involving the central nervous system. This report is of a patient with type 1 diabetes and a rare case of non-paraneoplastic limbic encephalitis mediated by anti-GAD65 antibodies that improved with the use of immunosuppressive drugs.
Type de document :
Article dans une revue
Diabetes and Metabolism, Elsevier Masson, 2012, 38 (3), pp.273-5. 〈10.1016/j.diabet.2012.02.005〉
Liste complète des métadonnées
https://hal.inria.fr/hal-00793692
Contributeur : Olivier Colliot <>
Soumis le : vendredi 22 février 2013 - 17:58:12
Dernière modification le : mercredi 21 mars 2018 - 18:57:48

Identifiants

Collections

UPMC | ICM

Citation

M. Lopez-Sublet, H. Bihan, G. Reach, Sophie Dupont, A. Didelot, et al.. Limbic encephalitis and type 1 diabetes with glutamic acid decarboxylase 65 (GAD65) autoimmunity: improvement with high-dose intravenous immunoglobulin therapy.. Diabetes and Metabolism, Elsevier Masson, 2012, 38 (3), pp.273-5. 〈10.1016/j.diabet.2012.02.005〉. 〈hal-00793692〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

95

Contact


archive-ouverte@inria.fr